Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Norwalk virus VP1 capsid protein is the major structural protein of the Norwalk virus (a genogroup I human norovirus), forming the icosahedral T=3 symmetry capsid with 180 copies organized as 90 dimers, approximately 38-410 Å in diameter. It consists of an N-terminal arm (NTA), shell domain (S, residues ~41-213, eight-stranded β-barrel forming the inner shell), and protruding domain (P, residues ~222-540, divided into P1 and P2 subdomains, forming surface spikes). The S and P domains are linked by a flexible hinge (~residues 213-222), enabling conformational changes between 'resting' (P domain close to S) and 'raised/rising' (P elevated) states, influenced by divalent ions (e.g., Cd2+) at P domain dimer interfaces for stability. The P2 subdomain mediates strain-specific glycan binding for cell attachment. VP1 self-assembles into virus-like particles (VLPs); co-expression with minor protein VP2 enhances stability but VP2 is internal and low-copy. Flexibility aids replication, antigen presentation, and vaccine design challenges due to antigenic variation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norwalk virus VP1 capsid protein (VP1).